Everest Group (EG) is trading down at $365.08 (-0.48%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Financials sector.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.79B | $6.62B | $7.36B | $8.23B | $9.60B | $11.9B | $12.1B | $14.6B | $17.3B | $17.5B |
| Growth (year over year) | +2.1% | +14.3% | +11.2% | +11.8% | +16.6% | +23.6% | +1.6% | +21.0% | +18.5% | +1.2% |
| Net income | $792.4M | $272.6M | −$125.8M | $766.4M | $262.0M | $1.38B | $597.0M | $2.52B | $1.37B | $1.59B |
| Net margin | 13.7% | 4.1% | −1.7% | 9.3% | 2.7% | 11.6% | 5.0% | 17.3% | 7.9% | 9.1% |
| EPS (diluted) | $23.68 | $11.70 | $2.17 | $24.70 | $12.78 | $34.62 | $15.19 | $60.19 | $31.78 | $37.80 |
| Balance sheet | ||||||||||
| Cash and equivalents | $481.9M | $635.1M | $656.1M | $808.0M | $802.0M | $1.44B | $1.40B | $1.44B | $1.55B | $1.32B |
| Total assets | $21.3B | $23.6B | $24.8B | $27.3B | $32.7B | $38.2B | $40.0B | $49.4B | $56.3B | $62.5B |
| Total liabilities | $13.2B | $15.2B | $16.9B | $18.2B | $23.0B | $28.0B | $31.5B | $36.2B | $42.5B | $47.1B |
| Shareholders' equity | $8.08B | $8.34B | $7.86B | $9.13B | $9.73B | $10.1B | $8.44B | $13.2B | $13.9B | $15.5B |
| Cash flow | ||||||||||
| Operating cash flow | $1.38B | $1.16B | $610.1M | $1.85B | $2.87B | $3.83B | $3.69B | $4.55B | $4.96B | $3.07B |
| Dividends paid | $195.4M | $207.2M | $216.2M | $234.3M | $249.0M | $247.0M | $255.0M | $288.0M | $334.0M | $335.0M |
| Share buybacks | $386.3M | $50.0M | $75.3M | $24.6M | $200.0M | $225.0M | $61.0M | $0 | $200.0M | $797.0M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.29B | $4.64B | $4.26B | $4.49B | $4.32B | $4.42B | $4.07B | $3.96B |
| Growth (year over year) | +7.4% | +26.7% | +3.1% | +6.2% | +0.8% | −4.6% | −4.6% | −11.8% |
| Net income | $509.0M | −$593.0M | $210.0M | $680.0M | $255.0M | $446.0M | $653.0M | $559.0M |
| Net margin | 11.9% | −12.8% | 4.9% | 15.1% | 5.9% | 10.1% | 16.1% | 14.1% |
| EPS (diluted) | $11.80 | −$13.59 | $4.90 | $16.10 | $6.09 | $10.71 | $16.21 | $14.22 |
| Balance sheet | ||||||||
| Cash and equivalents | $1.60B | $1.55B | $1.57B | $1.90B | $1.54B | $1.32B | $1.42B | $1.12B |
| Total assets | $55.9B | $56.3B | $58.1B | $60.5B | $62.2B | $62.5B | $62.3B | $62.2B |
| Total liabilities | $40.5B | $42.5B | $44.0B | $45.5B | $46.9B | $47.1B | $47.1B | $46.7B |
| Shareholders' equity | $15.3B | $13.9B | $14.1B | $15.0B | $15.4B | $15.5B | $15.3B | $15.4B |
| Cash flow | ||||||||
| Operating cash flow | $1.74B | $780.0M | $928.0M | $1.08B | $1.46B | −$398.0M | $649.0M | $290.0M |
| Dividends paid | $86.0M | $85.0M | $85.0M | $84.0M | $84.0M | $82.0M | $80.0M | $78.0M |
| Share buybacks | $100.0M | $0 | $200.0M | $200.0M | $0 | $397.0M | $330.0M | $395.0M |
From Everest Group's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Everest Group completes sale of Canadian retail unit
Everest Group completes sale of Canadian retail unit
Is Everest Group Stock Underperforming the Dow?
Is Everest Group Stock Underperforming the Dow?
$40 Trillion US Debt Is 72 Times Mount Everest in Cash: Market Strategist Says the Number Looks ‘Scary’ Until You See How Much Americans Own
$40 Trillion US Debt Is 72 Times Mount Everest in Cash: Market Strategist Says the Number Looks ‘Scary’ Until You See How Much Americans Own
Earnings call transcript: Everest Medicines posts H1 profit inflection, shares sink 13%
Earnings call transcript: Everest Medicines posts H1 profit inflection, shares sink 13%